Perennial Allergic Rhinitis clinical trials

Explore recruiting perennial allergic rhinitis clinical trials.

Recruiting perennial allergic rhinitis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Perennial Allergic Rhinitis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Lebrikizumab/ LY3650150 in Adult Participants With Perennial Allergic Rhinitis

Poland, Germany, Belgium

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective, randomised, double-blind, placebo-controlled multicenter clinical trial to evaluate efficacy and safety of immunotherapy in patients with rhinitis/rhinoconjunctivitis with or without mild to moderate asthma, allergic to Dermatophagoides pteronyssinus and/or Dermatophagoides farinae and Lepidoglyphus destructor.

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective, randomised, double-blind, placebo-controlled multicenter clinical trial to evaluate efficacy and safety of immunotherapy in patients with rhinitis/rhinoconjunctivitis with or without mild to moderate asthma, allergic to Dermatophagoides pteronyssinus and/or Dermatophagoides farinae and Blomia tropicalis

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective, multicenter, randomized, double-blind, placebo-controlled, efficacy and safety clinical trial with subcutaneous immunotherapy in patients with rhinitis/rhinoconjunctivitis with or without mild to moderate asthma sensitized to Dermatophagoides pteronyssinus and/or Dermatophagoides farinae

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective, multicentre, randomized, double-blind, placebo-controlled clinical trial of efficacy and safety with subcutaneous immunotherapy in patients with rhinitis/rhinoconjunctivitis with or without mild to moderate asthma sensitized to grasses and olive tree

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Prospective, multicentre, randomized, double-blind, placebo-controlled, clinical trial of efficacy and safety with subcutaneous immunotherapy in patients with rhinitis/rhinoconjunctivitis with or without mild to moderate asthma sensitized to grasses and cupressaceae

Spain

Therapeutic confirmatory (Phase III) EU CTIS Study details

Perennial Allergic Rhinitis trials by city

Perennial Allergic Rhinitis in Toronto Perennial Allergic Rhinitis in Vancouver Perennial Allergic Rhinitis in Montreal Perennial Allergic Rhinitis in Calgary Perennial Allergic Rhinitis in Edmonton Perennial Allergic Rhinitis in Ottawa Perennial Allergic Rhinitis in Winnipeg Perennial Allergic Rhinitis in Quebec City Perennial Allergic Rhinitis in Hamilton Perennial Allergic Rhinitis in Kitchener Perennial Allergic Rhinitis in London Perennial Allergic Rhinitis in Halifax Perennial Allergic Rhinitis in New York Perennial Allergic Rhinitis in Los Angeles Perennial Allergic Rhinitis in Chicago Perennial Allergic Rhinitis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease